BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/10/2023 8:15:35 AM | Browse: 470 | Download: 1819
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 81765
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Basic Study
Article Title Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
Manuscript Source Unsolicited Manuscript
All Author List Tai-Liang Lu, Cheng-Long Li, Yong-Qiang Gong, Fu-Tao Hou and Chao-Wu Chen
ORCID
Author(s) ORCID Number
Yong-Qiang Gong http://orcid.org/0000-0002-9215-8790
Chao-Wu Chen http://orcid.org/0000-0003-0653-4102
Funding Agency and Grant Number
Corresponding Author Chao-Wu Chen, MD, Chief Physician, Department of General Surgery, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, No. 61 Jiefang Xi Road, Furong District, Changsha 410005, Hunan Province, China. dr.chencw@hunnu.edu.cn
Key Words mRNA vaccine; Hepatocellular carcinoma; Immunotype; Antigens; Immune subtypes
Core Tip In this study, bioinformatics methods were used to explore novel hepatocellular carcinoma (HCC)-specific antigens for mRNA vaccine development and construct an immune subtype of HCC to select the appropriate vaccination population. Tumor-specific antigens were defined as highly expressed, genetically altered, and prognostic genes associated with antigen-presenting cell infiltration. AURKA, CCNB1, CDC25C, CDK1, TRIP13, PES1, MCM3, PPM1G, NEK2, KIF2C, PTTG1, KPNA2, and PRC1 were recognized candidate HCC antigens for mRNA vaccine development. The IS1 and IS3 immune subtypes of HCC were suitable populations for mRNA vaccination. RBP4, KNG1, METTL7A, F12, and ABAT were potential biomarkers for mRNA vaccines.
Publish Date 2023-10-10 08:15
Citation Lu TL, Li CL, Gong YQ, Hou FT, Chen CW. Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development. World J Gastrointest Oncol 2023; 15(10): 1717-1738
URL https://www.wjgnet.com/1948-5204/full/v15/i10/1717.htm
DOI https://dx.doi.org/10.4251/wjgo.v15.i10.1717
Full Article (PDF) WJGO-15-1717-with-cover.pdf
Full Article (Word) WJGO-15-1717.docx